LakeShore Biopharma Calls for Shareholder Vote on Stock Compliance
Company Announcements

LakeShore Biopharma Calls for Shareholder Vote on Stock Compliance

LakeShore Biopharma (LSB) has released an update.

LakeShore Biopharma has announced an extraordinary general meeting (EGM) for shareholders on September 27, 2024, to vote on resolutions aimed at regaining compliance with Nasdaq’s minimum bid price requirement, including a proposed share consolidation. The meeting will be held virtually via Zoom, with detailed instructions provided for shareholders to join. The board of directors fully endorses the proposed actions and encourages shareholder participation and approval.

For further insights into LSB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskLakeShore Biopharma Advances PIKA Rabies Vaccine Approval
TheFlyLakeShore Biopharma initiates BLA submission to DRAP for PIKA rabies vaccine
TipRanks Auto-Generated NewsdeskLakeShore Biopharma Announces Leadership Transition
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App